Organization
U.S. Food and Drug Administration
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
U.S. Food and Drug Administration
... is not terribly surprising: Between 2009 and 2015, the company received eight FDA warning letters and announced a steady drumbeat of recalls. At Rocky Mount, ...
... any suspected fetal exposure to REVLIMID to theFDAvia the MedWatch program at 1-800-FDA=15%) included neutropenia (51.3%), fatigue and asthenia (46.7%), upper respiratory tract infection (31%), ...
... has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its DTRAX® Spinal System ("DTRAX") to be specifically indicated for use ...
... National Pediculosis Association® (NPA) has submitted a petition to the US Food and Drug Administration (FDA) requesting that it update its website and other educational ...
... Closure and Cardiovascular suturing in the European Union. The NobleStitch(TM) EL is FDA cleared for Vascular and Cardiovascular suturing in the United States. Further information ...
... on consumer out-of-pocket spending that likely decreases drug adherence and health outcomes." FDA Commissioner Scott Gottlieb was even blunter in a speech the week before ...
... Those are big numbers for Hemlibra, which is awaiting word from the FDA on its bid for approval in hemophilia patients without factor VIII inhibitors. ...
... ("NDA") for Ozanimod were insufficient to permit a complete review by the FDA, which resulted in the FDA issuing a refusal to file letter to ...
... treatment of burn injuries is currently under review by the U.S. Food and Drug Administration (FDA). The Company expects completion of the FDA review of ...
... FDA Approves Prolia® (Denosumab) For Glucocorticoid-Induced Osteoporosis ...
Subscribe now for full coverage on U.S. Food and Drug Administration
Start My Free Trial